✦ LIBER ✦

Lymphocyte cytotoxicity of patients developing multiple primary melanomas

✍ Scribed by Bijay Mukherji; Yogeshwar Dayal

Publisher: John Wiley and Sons
Year: 1980
Tongue: English
Weight: 605 KB
Volume: 46
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19801001)46:7<1566::aid-cncr2820460712>3.0.co;2-v

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytotoxic lymphocytes in melanoma patien

Cytotoxic lymphocytes in melanoma patients

✍ Jan E. De Vries; Philip Rümke; Jean L. Bernheim 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 French ⚖ 670 KB

## Abstract Peripheral blood lymphocytes from 61 melanoma patients were tested by a microcytotoxicity test for cell‐mediated immunity against melanoma cells. Lymphocytes from 13/25 patients were cytotoxic for autologous tumour cells, while lymphocytes from 31/56 patients were cytotoxic in the allog

Tumour-associated lymphocyte cytotoxicit

Tumour-associated lymphocyte cytotoxicity superimposed on “Spontaneous” cytotoxicity in melanoma patients

✍ Jan E. De Vries; Philip Rümke 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 French ⚖ 674 KB

## Abstract Lymphocytes from 16 stage 1, 6 stage II and 31 stage III melanoma patients (MP) and 51 healthy donors (HD) were tested as far as possible in parallel on a melanoma cell line (NK1‐4), a bladder carcinoma cell line (T 24) and 18 different short‐term melanoma cultures. Lymphocytes from MP

Lymphocyte subpopulations in patients wi

Lymphocyte subpopulations in patients with multiple primary tumors

✍ Eliezer Robinson; Ruth Segal; Lily Struminger; David Faraggi; Ruchama El'ad-Yaru 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 2 views

## BACKGROUND. Cancer patients with single tumors live longer today due to earlier detection and improved treatment methods. For this reason, the authors see more patients who develop a second primary tumor. The etiology of the second tumor can be the same as the first, whether treatment-induced or

Multiple primary malignancies in patient

Multiple primary malignancies in patients with cutaneous melanoma

✍ Robert E. Bellet; Isaac Vaisman; Michael J. Mastrangelo; Edward Lustbader 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 633 KB

Population-based prevalence of CDKN2A an

Population-based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomas

✍ Per Helsing; Dag Andre Nymoen; Sarah Ariansen; Solrun J. Steine; Lovise Maehle; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB 👁 1 views

## Abstract The presence of multiple primary cutaneous melanomas (MPM) has been advocated as guidance to identifying melanoma families. Frequencies of __CDKN2A__ mutations in materials of sporadic MPM cases from pigmented lesion clinics vary between 8 and 15%. Patients with MPM have therefore been

New founder germline mutations of CDKN2A

New founder germline mutations of CDKN2A in melanoma-prone families and multiple primary melanoma development in a patient receiving levodopa treatment

✍ Caroline Kannengiesser; Stéphane Dalle; Marie-Thérèse Leccia; Marie Françoise Av 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB 👁 1 views

## Abstract Germline mutations in the __CDKN2A__ gene have been shown to predispose individuals to cutaneous malignant melanoma. Here, we describe three melanoma‐prone families and one isolated patient affected by multiple melanoma who carried a tandem germline mutation of __CDKN2A__ at the nucleot